647 related articles for article (PubMed ID: 29288686)
1. Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.
Roseman L; Demetriou L; Wall MB; Nutt DJ; Carhart-Harris RL
Neuropharmacology; 2018 Nov; 142():263-269. PubMed ID: 29288686
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.
Mertens LJ; Wall MB; Roseman L; Demetriou L; Nutt DJ; Carhart-Harris RL
J Psychopharmacol; 2020 Feb; 34(2):167-180. PubMed ID: 31941394
[TBL] [Abstract][Full Text] [Related]
3. Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.
Stroud JB; Freeman TP; Leech R; Hindocha C; Lawn W; Nutt DJ; Curran HV; Carhart-Harris RL
Psychopharmacology (Berl); 2018 Feb; 235(2):459-466. PubMed ID: 29085980
[TBL] [Abstract][Full Text] [Related]
4. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
[TBL] [Abstract][Full Text] [Related]
5. Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: an fMRI and pattern classification study.
Grotegerd D; Stuhrmann A; Kugel H; Schmidt S; Redlich R; Zwanzger P; Rauch AV; Heindel W; Zwitserlood P; Arolt V; Suslow T; Dannlowski U
Hum Brain Mapp; 2014 Jul; 35(7):2995-3007. PubMed ID: 24038516
[TBL] [Abstract][Full Text] [Related]
6. Blunted amygdala activity is associated with depression severity in treatment-resistant depression.
Ferri J; Eisendrath SJ; Fryer SL; Gillung E; Roach BJ; Mathalon DH
Cogn Affect Behav Neurosci; 2017 Dec; 17(6):1221-1231. PubMed ID: 29063521
[TBL] [Abstract][Full Text] [Related]
7. Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Barrett FS; Doss MK; Sepeda ND; Pekar JJ; Griffiths RR
Sci Rep; 2020 Feb; 10(1):2214. PubMed ID: 32042038
[TBL] [Abstract][Full Text] [Related]
8. Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.
Grimm O; Kraehenmann R; Preller KH; Seifritz E; Vollenweider FX
Eur Neuropsychopharmacol; 2018 Jun; 28(6):691-700. PubMed ID: 29703645
[TBL] [Abstract][Full Text] [Related]
9. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study.
Miskowiak KW; Kessing LV; Ott CV; Macoveanu J; Harmer CJ; Jørgensen A; Revsbech R; Jensen HM; Paulson OB; Siebner HR; Jørgensen MB
J Psychopharmacol; 2017 Sep; 31(9):1215-1224. PubMed ID: 28351201
[TBL] [Abstract][Full Text] [Related]
10. Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.
Aaronson ST; van der Vaart A; Miller T; LaPratt J; Swartz K; Shoultz A; Lauterbach M; Sackeim HA; Suppes T
JAMA Psychiatry; 2024 Jun; 81(6):555-562. PubMed ID: 38055270
[TBL] [Abstract][Full Text] [Related]
11. Increased low-frequency brain responses to music after psilocybin therapy for depression.
Wall MB; Lam C; Ertl N; Kaelen M; Roseman L; Nutt DJ; Carhart-Harris RL
J Affect Disord; 2023 Jul; 333():321-330. PubMed ID: 37094657
[TBL] [Abstract][Full Text] [Related]
12. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Carhart-Harris RL; Bolstridge M; Rucker J; Day CM; Erritzoe D; Kaelen M; Bloomfield M; Rickard JA; Forbes B; Feilding A; Taylor D; Pilling S; Curran VH; Nutt DJ
Lancet Psychiatry; 2016 Jul; 3(7):619-27. PubMed ID: 27210031
[TBL] [Abstract][Full Text] [Related]
13. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.
Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; Evans J; Feilding A; Wise RG; Nutt DJ
Br J Psychiatry; 2012 Mar; 200(3):238-44. PubMed ID: 22282432
[TBL] [Abstract][Full Text] [Related]
14. Brain activation in response to overt and covert fear and happy faces in women with borderline personality disorder.
Cullen KR; LaRiviere LL; Vizueta N; Thomas KM; Hunt RH; Miller MJ; Lim KO; Schulz SC
Brain Imaging Behav; 2016 Jun; 10(2):319-31. PubMed ID: 26007149
[TBL] [Abstract][Full Text] [Related]
15. Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.
Carrillo F; Sigman M; Fernández Slezak D; Ashton P; Fitzgerald L; Stroud J; Nutt DJ; Carhart-Harris RL
J Affect Disord; 2018 Apr; 230():84-86. PubMed ID: 29407543
[TBL] [Abstract][Full Text] [Related]
16. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
[TBL] [Abstract][Full Text] [Related]
17. Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression.
Miskowiak KW; Glerup L; Vestbo C; Harmer CJ; Reinecke A; Macoveanu J; Siebner HR; Kessing LV; Vinberg M
Psychol Med; 2015 May; 45(7):1447-58. PubMed ID: 25382193
[TBL] [Abstract][Full Text] [Related]
18. Neural correlates of perception of emotional facial expressions in out-patients with mild-to-moderate depression and anxiety. A multicenter fMRI study.
Demenescu LR; Renken R; Kortekaas R; van Tol MJ; Marsman JB; van Buchem MA; van der Wee NJ; Veltman DJ; den Boer JA; Aleman A
Psychol Med; 2011 Nov; 41(11):2253-64. PubMed ID: 21557888
[TBL] [Abstract][Full Text] [Related]
19. Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.
Shukuroglou M; Roseman L; Wall M; Nutt D; Kaelen M; Carhart-Harris R
J Psychopharmacol; 2023 Jan; 37(1):70-79. PubMed ID: 36433778
[TBL] [Abstract][Full Text] [Related]
20. Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.
Stoliker D; Novelli L; Vollenweider FX; Egan GF; Preller KH; Razi A
Biol Psychiatry; 2024 Jul; 96(1):57-66. PubMed ID: 38185235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
